Incline Sleeper Lawsuit: Rock ‘n Play Settlement, Recalls & Federal Ban

Lawsuits over inclined infant sleepers have produced a $19 million consumer class action settlement covering Fisher-Price Rock ‘n Play buyers, a wave of wrongful death and injury cases that Mattel quietly settled in June 2025 on the eve of trial, and a federal ban that made the entire product category illegal to sell in the United States. If you owned a Rock ‘n Play, you may still be able to file a late claim through March 31, 2027. If a child in your family died or was injured in one of these products, that is a separate case, not part of the class settlement.

The Rock ‘n Play Class Action Settlement

Fisher-Price and Mattel agreed in July 2024 to a $19 million fund to resolve consumer claims brought in the multidistrict litigation In Re: Fisher-Price Rock ‘N Play Sleeper Marketing, Sales Practices, and Products Liability Litigation. The court approved the deal on February 28, 2025, and it became effective March 31, 2025.

The class is broad. It covers anyone in the United States, D.C., Puerto Rico, or U.S. territories who bought, acquired, or still had a Rock ‘n Play Sleeper between January 1, 2009, and September 18, 2024. Payment depends on when you bought the product, whether you still have it, and whether you can produce proof of purchase:

  • Current owners with proof of purchase from October 2018 through April 2019 receive a full purchase-price refund.
  • Current owners without proof from that same window receive $60.
  • Current owners of older models receive $40 to $50, depending on purchase date.
  • Former owners with proof of purchase receive $25 to $35, depending on purchase date.
  • Former owners without proof receive $10.
  • Anyone who already returned the product in the original recall for a voucher or toy receives $10.

If You Missed the Main Claims Deadline

The primary deadline for claims was May 29, 2025. Class members who did not know about the settlement can still file through March 31, 2027, or until the fund runs out, whichever comes first. The Rock ‘n Play was sold in enormous volume — roughly 4.7 million units — so eligibility is common; the practical question is whether you file before the money is gone.

Wrongful Death and Serious Injury Cases

The class action settled economic losses from buying a defective product. Families whose infants died or were seriously injured filed separate wrongful death and personal injury lawsuits, and more than 35 such cases were brought against Fisher-Price and Mattel.

The most significant resolution came in June 2025. During the week of June 2, court filings in Delaware Superior Court disclosed that Mattel had settled ten individual cases — six deaths and four serious injuries — just days before jury selection was to begin in Brown v. Fisher-Price, brought by Ameena Brown over her infant son’s death. Financial terms were not disclosed.1

Mattel did not concede liability. In the Brown case, the company argued the mother had failed to use the product’s restraints and attributed the death to Sudden Infant Death Syndrome. Testifying before Congress in 2021, Mattel CEO Ynon Kreiz and Fisher-Price Senior VP Chuck Scothon maintained the product was safe when used according to instructions.

By the time the CPSC reannounced the recall in 2023, the confirmed Rock ‘n Play death toll was roughly 100, including at least eight deaths after the original 2019 recall. A family in that situation is not filing a class-action claim form; they are working with a products liability attorney on an individual case.

What the Lawsuits Alleged

The claims against Fisher-Price and Mattel rested on three theories. First, defective design: the roughly 30-degree incline combined with a soft, curved surface created a suffocation hazard and contradicted the American Academy of Pediatrics’ guidance that infants sleep on a firm, flat surface. Second, negligent testing: before launch in October 2009, the company consulted a single family medicine doctor rather than a pediatrician, tested only 62 infants, and had no medical doctors analyze the results. Third, failure to warn and failure to act: Fisher-Price’s own Safety Committee flagged the design as “unacceptable” three times between August 2008 and February 2009, international regulators objected as early as 2010, Canada banned the product as a sleeper in 2011, and a board-certified pediatrician wrote to the company in 2013 warning it was unsafe for routine sleep. The recall did not come until April 12, 2019, days after Consumer Reports linked the product to at least 32 infant deaths.

A 2021 U.S. House Committee on Oversight and Reform investigation concluded Fisher-Price acted only after Consumer Reports obtained CPSC fatality data and prepared to publish. Rep. Raja Krishnamoorthi told executives at a hearing: “You only acted because you got caught red-handed.”

Other Inclined Sleepers and Related Products

The Rock ‘n Play was the most prominent case, but not the only one. Between January 2005 and June 2019, the CPSC documented 1,108 incidents involving inclined infant sleep products from various manufacturers, including 73 infant deaths.

Graco recalled about 51,000 inclined sleeper accessories in December 2020, covering inserts sold with the Pack ‘n Play Day2Dream, Nuzzle Nest, Everest, and Rock ‘n Grow playards. No deaths were tied to those specific accessories, and Graco refunded the accessory component. The company had also recalled roughly 111,000 Little Lounger Rocking Seats in January 2020.

Chicco USA was sued by Jayme and Lakin Minnich after their three-month-old son Cayson suffocated in May 2017 while sleeping in an inclined “napper” insert sold with the Chicco Lullaby Dream Playard. Chicco denied the product was defective. The case’s final outcome has not been publicly reported.

In October 2024, Fisher-Price recalled about 2.1 million Snuga Infant Swings after five infant deaths were reported between 2012 and 2022 when the swings were used for sleep. Instead of full refunds, Fisher-Price offered $25 to owners who cut out and destroyed the headrest and body support insert. CPSC Commissioner Richard Trumka and Consumer Reports criticized that remedy as insufficient.

The Federal Ban and Current Safety Rule

The Safe Sleep for Babies Act of 2021, signed into law on May 16, 2022, banned inclined sleepers for infants, defined as products with a sleep surface angled more than 10 degrees intended for children up to one year old. The ban took effect November 12, 2022. It is now illegal to sell, manufacture, distribute, or import these products in the United States, regardless of when they were made. That applies to retailers and resellers; the law does not create a private cause of action for someone who still owns one.

A separate CPSC standard for infant support cushions and loungers, codified at 16 CFR part 1243, took effect May 5, 2025. It sets firmness requirements, a 10-degree maximum incline, side-angle specifications to prevent entrapment, and mandatory warning labels for infant loungers, infant pillows, and nursing pillows with a lounging function.

Why Deaths Continue After Recalls

A 2026 study in Pediatrics by researchers at the National Center for Fatality Review and Prevention identified 158 sudden unexpected infant deaths in inclined sleepers between 2009 and 2023. Thirty-two percent occurred after the 2019 recalls. Eighty-six percent of deaths happened at home, 83 percent while a parent was supervising, and 66 percent involved infants younger than four months. In roughly a third of cases, full or partial airway obstruction was identified, most often caused by the sleeper material itself.

The authors noted that new warning labels telling caregivers not to use certain products for sleep “may have caused confusion for caregivers about which products were safe for infant sleep.” Plaintiffs’ attorneys have increasingly focused on post-recall failures, arguing manufacturers have not done enough to remove recalled products from secondhand markets and hand-me-down channels. If you have an inclined sleeper in your home from any manufacturer, it should not be used for infant sleep, and the products covered by the 2022 ban cannot legally be resold.

  • 1